Editor's Note :

Editor's Note :

On Monday we expect the Court to issue orders from the June 23 Conference at 9:30 a.m. and opinions in one or more argued cases at 10 a.m. We will begin live-blogging at 9 a.m.
The blog is hosting a symposium on the Court's opinion in Fisher v. University of Texas at Austin.
The blog is also hosting a symposium on the Court's ruling in United States v. Texas.

Louisiana Wholesale Drug Co. v. Bayer AG

Petition for certiorari denied on March 7, 2011
Docket No. Op. Below Argument Opinion Vote Author Term
10-762 2d Cir. N/A N/A N/A N/A OT 2010

Issue: Whether, absent patent fraud or sham litigation, a brand drug maker's substantial payment to a competing generic drug maker to forgo judicial testing of the patent and restrict entry is per se lawful under the Sherman Act.

Briefs and Documents

Certiorari-stage documents

 
Share:
Term Snapshot
Awards